Pharmacotherapy for treatment-refractory schizophrenia

Author： Van Sant Scott P Buckley Peter F

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.3, 2011-02, pp. : 411-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite

Tacrolimus superior for treatment-refractory RA

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pegloticase: In Treatment-Refractory Chronic Gout

By Lyseng-Williamson Katherine A.

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2179-2192

Adis International

Access to resources Recommend Favorite

Risperidone effective for treatment-refractory depression

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Clinical efficacy of clozapine in treatment-refractory schizophrenic patients

By Min-Soo L. In-Kwa J. Dong-Il K.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 342-342

Elsevier

Access to resources Recommend Favorite